Key terms

About MTNB

Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company. It engages in the business of delivering groundbreaking therapies using lipid nanocrystal platform delivery technology to maximize global clinical impact and patient access. The company was founded by Herbert J. Conrad and Jerome D. Jabbour in May 2013 and is headquartered in Bedminster, NJ.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest MTNB news

Apr 05 7:12am ET Matinas BioPharma’s Multi-Million Share Sale and Lock-Up Deal by TipRanks Apr 03 8:39am ET Matinas BioPharma prices 33.33M shares at 30c in registered direct offering by TipRanks Apr 02 10:35am ET Matinas BioPharma (MTNB) Gets a Buy from Maxim Group by TipRanks Mar 28 9:13am ET Matinas BioPharma Updates Presentation for Investor Outreach by TipRanks Mar 25 8:31am ET Matinas announces in vivo safety data with oral LNC-doxetaxel formulation by TipRanks Mar 25 8:22am ET Matinas BioPharma’s LNC Technology Promises Safer Chemotherapy by TipRanks Mar 22 9:33am ET Matinas BioPharma’s MAT2203 Shows Promising Clinical Results by TipRanks Mar 22 6:31am ET Matinas BioPharma regains compliance with NYSE American by TipRanks Feb 26 8:22am ET Matinas BioPharma’s MAT2203 Shows Renal Improvement and Infection Recovery by TipRanks Feb 26 8:09am ET Matinas BioPharma provides update from Compassionate/EUA Program with MAT2203 by TipRanks Feb 20 7:52am ET Matinas BioPharma Advances MAT2203 in Phase 3 Global Trial by TipRanks Feb 20 7:35am ET Matinas BioPharma reaches agreement with FDA for Phase 3 trial of MAT2203 by TipRanks Jan 07 5:41am ET BTIG Sticks to Their Buy Rating for Matinas BioPharma (MTNB) by TipRanks

No recent press releases are available for MTNB

MTNB Financials

1-year income & revenue

Key terms

MTNB Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

MTNB Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

In this photo illustration, Republican presidential candidate former President Donald Trump's social media platform Truth Social is shown on a cell phone on March 25, 2024 in Chicago, Illinois.
Scott Olson/Getty Images
Trump’s stock tumbles again after Truth Social announces it’s getting into streaming
Tim Wren, chief commercial officer for BSI Group, right, presents Kristalina Georgieva, chief executive officer of the World Bank Group, second right, with ISO 20121 certification for sustainable event management at an event during the spring meetings of the International Monetary Fund (IMF) and World Bank in Washington, DC, US, on Monday, April 15, 2024. The IMF and World Bank spring meetings in Washington are expected to draw thousands of delegates, observers and journalists from the fund's 190 member countries. Photographer: Samuel Corum/Bloomberg via Getty Images
Samuel Corum/Bloomberg/Getty Images
Geopolitical strife is roiling Wall Street. Here’s what investors are watching
Donald Trump might no longer own a majority of TMTG after a new public share offering.
Joe Raedle/Getty Images
Trump stock tanks after announcing massive share sale
1040 US Individual Income Tax Return Form
Nora Carol Photography/Moment RF/Getty Images
Three ways investors can minimize their tax payments